FLULAVAL QUADRIVALENT
STN: BL 125163
Proper Name: Influenza Vaccine
Tradename: FluLaval Quadrivalent
Manufacturer: ID Biomedical Corporation of Quebec
Indication:
- For active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Approved for use in persons aged 6 months and older.
Product Information
Supporting Documents
- July 13, 2023 Approval Letter - FLULAVAL QUADRIVALENT
- July 1, 2022 Approval Letter - FluLaval Quadrivalent
- July 2, 2021 Approval Letter - FluLaval
- July 2, 2020 Approval Letter - FluLaval
- February 6, 2020 Approval Letter - FluLaval
- July 2, 2019 Approval Letter - FluLaval
- June 29, 2018 Approval Letter - FluLaval Quadrivalent
- July 7, 2017 Approval Letter - FluLaval Quadrivalent
To include the 2017-2018 United States formulation and associated labeling revisions. - Statistical Review and Evaluation - FluLaval and FluLaval Quadrivalent
- Statistical Review Assay - FluLaval and FluLaval Quadrivalent
- Clinical Review - FluLaval and FluLaval Quadrivalent
- Supporting Documents older than three years - FluLaval Quadrivalent